The company’s midpoint estimate for adjusted earnings before interest, taxes, depreciation and amortization was $3.4 billion through the end of 2022, the company said in a Jan. 19 release.
“Our business units continued to demonstrate effective management capabilities and delivered strong results in the fourth quarter,” Saum Sutaria, MD, CEO of Tenet, said in the release. “All three of our business units are expected to produce adjusted EBITDA excluding grant income that was at or slightly above the midpoint of our guidance.”
The company also announced it was making nine executive changes, including USPI President and CEO Brett Brodnax retiring at the end of 2023.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
